HHMI
XYL icon

Howard Hughes Medical Institute’s Xylem XYL Stock Holding History

Howard Hughes Medical Institute’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52
Closed -$7.08K – 489
2025
Q4 		$7.08K Hold
52
– – ﹤0.01% 280
2025
Q3 		$7.67K Hold
52
– – ﹤0.01% 258
2025
Q2 		$6.73K Buy
+52
New +$6.3K ﹤0.01% 270

Other funds holding XYL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Howard Hughes Medical Institute's XYL Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Xylem (XYL) in Q1 2026, closing a stake of 52 shares — an estimated $7.08K sold.

Howard Hughes Medical Institute first reported a position in XYL in Q2 2025 and held it in 3 quarters. The position peaked at $7.67K in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 52 Xylem shares in Q1 2026, an estimated $7.08K.
  • Howard Hughes Medical Institute first reported a position in Xylem in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Xylem position peaked at $7.67K in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.